retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending ADA 2026: Retatrutide Revolution

A more accurate classification like ERZIAN scoring may allow for better discrimination between different disease phenotypes [2]

- Rendimiento deportivo y recuperacin muscular Tambin ha generado inters en el mbito deportivo

Bring your prescription label

23andMe has over 11 million people in their research database and used voluntary survey data on medication use, dosage, duration, weight loss, and side effects to match against genetic profiles at scale, making this one of the most powerful datasets anyone has brought to this question

Important: This article is for informational purposes only and does not constitute medical advice